Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Filings indexed 1,237 across all filing types
Latest filing 2025-06-18 Major Shareholding Noti…
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for the financial year ended March 31, 2025. It contains information about the Promoters and Promoter Group, including PAN details, and is addressed to stock exchanges. This type of disclosure relates to changes or notifications about substantial shareholdings or acquisitions, which fits the category of Major Shareholding Notification (MRQ). The document is short (2004 characters) and is a regulatory disclosure rather than a full report or announcement of a report publication. Therefore, the correct classification is MRQ with high confidence.
2025-06-18 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for the financial year ended March 31, 2025. This regulation pertains to reporting changes in substantial shareholdings or acquisitions. The document is a formal notification to stock exchanges (BSE and NSE) about shareholding disclosures from promoters and promoter groups. It is not a financial report, earnings release, or management discussion, but a regulatory notification about share ownership changes. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is short and it is a direct disclosure, not an announcement of a report or certification. Hence, the classification is MRQ with high confidence.
2025-06-18 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-06-18 English
In connection with the Postal Ballot Notice dated May 12, 2025, please find enclosed herewith the outcome of the Postal ballot along with the Scrutinizers Report and the Voting Results ....
Regulatory Filings
2025-06-12 English
In connection with the Postal Ballot Notice dated May 12, 2025, please find enclosed herewith the outcome of the Postal Ballot along with the Scrutinizer''s Report and Voting Results under ....
Regulatory Filings
2025-06-12 English
Shareholders meeting
Regulatory Filings
2025-06-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.